News & Media

Learn what’s new at Wheeler Bio

Filter By

All Articles Blogs Events News + PR Resources Videos

LinkedIN Personal Background 1 (656 x 450 px) (3)

News + PR

Wheeler Bio Named One of America’s Greatest Startup Workplaces 2026

September 22, 2026

News + PR

Wheeler Bio Appoints Rajesh Beri, Ph.D., as Chief Development Officer

July 21, 2026

News + PR

Wheeler Bio Launches New Website Reflecting Expansion of Capabilities, Clients Served, and a Commitment to High-Science, High-Touch Biologics Manufacturing

June 29, 2026

News + PR

OU–Industry Collaboration Harnesses AI to Accelerate Antibody Drug Production

February 10, 2026

News + PR

Wheeler Bio Announces Oversubscribed Series A-1, Plans for Expansion and Continued Growth

March 20, 2025

News + PR

Wheeler Bio Appoints Industry Veteran Patrick Lucy as Chief Executive Officer

October 9, 2024

News + PR

ISPE Announces 2024 Facility of the Year Awards Submission Finalists

March 13, 2024

News + PR

Wheeler Bio Announces Grand Opening of Biomanufacturing Facility

October 5, 2023

News + PR

Wheeler Bio Appoints Dr. Stewart McNaull as Chief Business Officer

June 6, 2023

News + PR

Wheeler Bio and Charles River Laboratories Announce Agreement to Build and Operate RightSource^SM Laboratory

May 31, 2023

News + PR

Wheeler Bio Announces Closing of $31 Million Series A Round Supporting its Clinical (CGMP) Drug Substance Manufacturing Facility in Oklahoma City

April 13, 2023

News + PR

Wheeler Bio Licenses ATUM’s Proprietary Leap-In Transposase® Technology in Support of its Disruptive CDMO Service Offering

December 14, 2022

Our Expert Team

Let’s Get Started

Wheeler is excited to collaborate on the path to accelerated clinical impact. Whether you’re an Innovator, a CRO, or a CDMO, we want to hear from you.